A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer
Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between...
Saved in:
Main Authors: | Xin Zhang, Xingda Zhang, Guozheng Li, Yi Hao, Lei Liu, Lei Zhang, Yihai Chen, Jiale Wu, Xinheng Wang, Shuai Yang, Shouping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/3143511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
by: Lingjuan Ruan, et al.
Published: (2018-01-01) -
mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer
by: E. D. Kulaeva, et al.
Published: (2024-05-01) -
Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
by: Jun-Yu Zhu, et al.
Published: (2022-01-01) -
Development of a Ten-lncRNA Signature Prognostic Model for Breast Cancer Survival: A Study with the TCGA Database
by: Wenqing Zhou, et al.
Published: (2020-01-01) -
Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer
by: Dedi Kong, et al.
Published: (2025-01-01)